Pachymeningeal Involvement with Blindness as the Presenting Manifestation of Non-Hodgkin Lymphoma

.

Rituximab-Related Reversible Hepatocellular Damage

To the Editor, Since its approval in 1997 by the US Food and Drug Administration, use of rituximab (MabThera®, Roche,Switzerland) has become widespread, especially for the treatment of non-Hodgkin lymphoma (NHL) and chr...

Multicenter Retrospective Analysis of Turkish Patients with Chronic Myeloproliferative Neoplasms

Objective: Chronic myeloproliferative neoplasms (CMPNs) that include polycythemia vera (PV), essential thrombocythemia (ET), and primary myelofibrosis (PMF) are Philadelphia-negative malignancies characterized by a clona...

The Role of Radiotherapy Among the Therapeutic Options for Castleman’s Disease

Oyun Çocuğunda, Geç Bulgu Veren Doğumsal Diyafram Hernisine Bağlı Ağır Demir Eksikliği Anemisi